Transgene: appointment of Steven Bloom as Director of Business Development

Transgene announces the appointment of Steven Bloom as Vice President, Director of Business Development (Chief Business Officer, CBO), effective immediately. He will join Transgene's Executive Committee to lead the development strategy, as well as the management of the Company's partnerships and programs. His role will be, in particular, to increase Transgene's visibility in the United States in order to strengthen its position as the world leader in immunotherapies based on viral vectors.

Prior to joining Transgene, Mr. Bloom was Senior Vice President at Boston Pharmaceuticals. Prior to that, he was Commercial Director at Vavotar Life Sciences (formerly known as NantiBodyFc). As part of his role at Vavotar, Steven Bloom, then a member of the executive committee, mainly managed corporate strategy, business development, and the development of contacts with opinion leaders. He notably co-led the sale of an antibody-drug conjugate platform in oncology and the integration of the team in Sorrento in November 2020. Mr. Bloom previously held similar positions at Verastem Oncology and Ziopharm Oncology. Earlier in his career, he worked for 18 years at Eli Lilly, where he held key positions in sales.